The role of L-methylfolate in depressive disorders. (Q37377390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

The role of L-methylfolate in depressive disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Andrew Farah

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

issue

1 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

2-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Atypicality of atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Late-onset depression: genetic, vascular and clinical contributions

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Methylenetetrahydrofolate reductase variant and schizophrenia/depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Serum and red blood cell folate in depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Nutrition and Depression: The Role of Folate

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

The homocysteine hypothesis of depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Treatment of depression: time to consider folic acid and vitamin B12

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Folate, B12, and life course of depressive illness

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Change in folate status with antidepressant treatment

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Chronic pain-associated depression: antecedent or consequence of chronic pain? A review

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

An open trial of methyltetrahydrofolate in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Enhancement of recovery from psychiatric illness by methylfolate.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Homocysteine and folate metabolism in depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Red cell folate concentrations in psychiatric patients

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Residual symptoms after partial remission: an important outcome in depression

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Depression following myocardial infarction. Impact on 6-month survival.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Depression and folate status in the US Population

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Use of treatment algorithms for depression.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Depression and tetrahydrobiopterin: the folate connection

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Folic acid enhances lithium prophylaxis

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

The biology of folate in depression: implications for nutritional hypotheses of the psychoses

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Depression and cardiac mortality: results from a community-based longitudinal study

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Association of depression witk reduced heart rate variability in coronary artery disease

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1017/S1092852950003473

7 January 2021

10.1017/S1092852950003473

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169195 AND SRC:MED&resulttype=core&format=json

20 January 2020

1 reference